z-logo
Premium
Combination of bortezomib in the induction, conditioning and consolidation with autologous hematopoietic stem cell transplantation in patients with immunoglobulin light chain amyloidosis
Author(s) -
Huang Xianghua,
Fu Chengcheng,
Chen Lijuan,
Chen Wencui,
Ren Guisheng,
Guo Jinzhou,
Zhao Liang,
Zeng Caihong,
Zhang Haitao,
Gong Dehua,
Ren Qiang,
Liu Zhihong
Publication year - 2019
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25404
Subject(s) - medicine , al amyloidosis , bortezomib , autologous stem cell transplantation , amyloidosis , multiple myeloma , plasma cell dyscrasia , melphalan , transplantation , hematopoietic stem cell transplantation , clinical trial , surgery , oncology , gastroenterology , immunology , antibody , immunoglobulin light chain

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom